TX-1123 is a potent protein tyrosine kinase (PTK) inhibitor targeting Src, eEF2-K, PKA, and EGFR-K/PKC; it is also a cyclooxygenase (COX) inhibitor with IC50 values of 1.16 μM and 15.7 μM for COX-2 and COX-1, respectively; it exhibits low mitochondrial toxicity and can be used in cancer research.